Author
Listed:
- Fahmida Binte Khair
(School of Business, International American University, Los Angeles, CA 90010, USA)
- Mohammad Muzahidur Rahman Bhuiyan
(College of Business, Westcliff University, Irvine, CA 92614, USA)
- Mia Md Tofayel Gonee Manik
(College of Business, Westcliff University, Irvine, CA 92614, USA)
- Shafaete Hossain
(School of Business, International American University, Los Angeles, CA 90010, USA)
- Md Shafiqul Islam
(Department of Computer Science, Maharishi International University, Iowa 52557, USA)
- Mohammad Moniruzzaman
(Department of Computer Science, Maharishi International University, Iowa 52557, USA)
- Abu Saleh Muhammad Saimon
(Department of Computer Science, Washington University of Science and Technology, Alexandria VA 22314, USA)
Abstract
Machine learning (ML) represents a breakthrough in drug discovery, markedly increasing efficiency in the search for plant-derived bioactive compounds with anticancer activity. While compounds derived from plants like vincristine and taxol are historical pillars of oncology, the emerging novel therapeutic agents aim to overcome limitations associated with classical therapies, such as toxicity and resistance. Some of the important ML algorithms in this context include decision trees, support vector machines, neural networks, and ensemble learning which allow predictions about bioactivity by managing complicated biological data and determining the effectiveness of different compounds while also optimizing therapeutic profiles. For anticancer compound discovery, supervised as well as unsupervised learning is used whereby activity can be predicted from known properties or compounds just clustered in huge phytochemical databases. Moreover, deep learning models are particularly adept at processing high-dimensional data like multi-omics data and discovering non-linear relationships which furthers our understanding of bioactive compounds at a systems level. While optimizing bioactive compounds, QSAR modeling alongside generative models helps in fine-tuning the molecular design for improved activity and reduced toxicity. ADMET profiling also ensures that the molecules are within the limits of pharmacokinetic and safety standards, thus smoothing out the passage from in silico predictions to experimental validation. The discussion closes with the consideration of some challenges, such as data integration, interpretability of models, computationally intensive tasks, and regulatory demands to be followed versus the promise of the future through cooperative platforms, accessible ML tools together with personalized medicine. Further emphasis is given on the need for continued research interdisciplinary collaborations as well as investments that will help harness the full potential of ML in plant-based anticancer drug discovery to improve treatment outcomes while minimizing adverse effects.
Suggested Citation
Fahmida Binte Khair & Mohammad Muzahidur Rahman Bhuiyan & Mia Md Tofayel Gonee Manik & Shafaete Hossain & Md Shafiqul Islam & Mohammad Moniruzzaman & Abu Saleh Muhammad Saimon, 2024.
"Machine Learning Approaches to Identify and Optimize Plant-Based Bioactive Compounds for Targeted Cancer Treatments,"
British Journal of Pharmacy and Pharmaceutical Sciences, Al-Kindi Center for Research and Development, vol. 1(1), pages 60-67, June.
Handle:
RePEc:alk:bjpps0:v:1:y:2024:i:1:id:8205
DOI: 10.32996/bjpps.2024.1.1.7
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:alk:bjpps0:v:1:y:2024:i:1:id:8205. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Al-Kindi Center for Research and Development (email available below). General contact details of provider: https://al-kindipublisher.com/index.php/bjpps .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.